Global Swine Pneumonia Market Size, Trends, and Growth Opportunity, By Diagnosis (Serologic Tests, Polymerase Chain Reaction (PCR) Test, Others), Treatment (Vaccination, Antibiotics, Antibacterial, Others), Mode of Consultation (Over-the-Counter (OTC), Prescription), End-Users (Veterinary Hospitals, Veterinary Specialty Clinics, Others), Distribution Channel (Veterinary Hospital Pharmacy, Retail Pharmacy, Veterinary Research Institute, Others) By Region and forecast till 2030.
Global Swine Pneumonia Market
Global Swine Pneumonia Market was valued at USD 524.60 million in 2022 and is slated to reach USD 861.10 million by 2023 at a CAGR of 6.39% from 2023-2030.
Pigs' health is impacted by swine pneumonia, a lower respiratory illness. This condition can result in lung inflammation, bacterial infection, extremely high pig death rates, as well as financial hardship for the swine business. Coughing and thumps are classic symptoms of pig pneumonia. Many investigations have shown that swine respiratory problems, which are one of the main killers of nursery pigs, are a concoction of several infectious diseases.
Market Drivers
Swine pneumonia is becoming more common, which is fueling the market's expansion. In 73.1% of the animals, pneumonic processes were observed. They mostly consisted of pleuritis (17.6%) and cranioventral bronchopneumonia (CBP; 46.3%). In addition, broncho interstitial pneumonia (67.4%) was frequent and was sometimes associated with interstitial pneumonia (27.9%). (IP). Pneumonia in pigs has been observed to be prevalent, and the incidence varies from 19% to 79% depending on the locale, the system of production, or the lung lesion grading method utilized. The condition now requires more intensive treatment methods as a result of its rising prevalence. This contributes to the market's expansion. Pneumonia is treated early on using a variety of symptoms and diagnostic techniques. Coughing, fast breathing, a high body temperature, and post-mortem investigations are typical clinical symptoms. To find the potential reasons, additional techniques are required, such as laboratory studies including serology and microbiology. So, each of these tests is crucial for identifying the condition.
Market Restraints
The market may become obstructed if there aren't enough qualified veterinarians who can treat pig pneumonia. If the condition is not appropriately managed, it can have a significant impact. Not all personnel are skilled enough to manage the pigs with the best possible care. An obstacle to market growth so exists.
Recent Developments
Bimeda Animal Health's EnroMed 100 medication for pigs with respiratory diseases was approved by the US FDA in May 2019.
The FDA in the United States approved Norbrook Labs' Cefenil in January 2019 for use in treating pigs with swine bacterial pneumonia.
Market Segmentation
Global Swine Pneumonia Market is segmented By Diagnosis, Treatment, Mode of Consultation, End-Users, and Distribution Channel. By Diagnoses such as Serologic Tests, Polymerase Chain Reaction (PCR) Tests, and Others. By Treatment such as Vaccination, Antibiotics, Antibacterial, and Others. By Mode of Consultation such as Over-the-Counter (OTC), Prescription. By End-Users such as Veterinary Hospitals, Veterinary Specialty Clinics, and Others. By Distribution channels such as Veterinary Hospital Pharmacy, Retail Pharmacies, Veterinary Research Institute, and Others.
Regional Analysis
Global Swine Pneumonia Market is segmented into five regions Americas, Europe, Asia-Pacific, and the Middle East & Africa. Due to the rising prevalence of swine pneumonia and subsequent rise in vaccine demand in this area, Asia-Pacific is predicted to expand during the swine pneumonia market forecast. The high level of healthcare infrastructure development will also accelerate market expansion in this area. Due to rising vaccination awareness among pet owners and rising healthcare costs in this region, North America will continue to hold a dominant position in the market during the projection period. Also, the existence of significant market participants will accelerate the rate of market expansion in this area.
Key Players
This report includes a list of numerous Key Players, namely Johnson & Johnson Private Limited (U.S.), Cipla Inc. (U.S.), Abbott (U.S.), AbbVie Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Aurobindo Pharma (India), Lupin (India), Sanofi (France), F. Hoffmann-La Roche Ltd. (Switzerland), Mallinckrodt (U.S.).
Market Taxonomy
By Diagnosis
• Serologic Tests
• Polymerase Chain Reaction (PCR) Test
• Others
By Treatment
• Vaccination
• Antibiotics
• Antibacterial
• Others
By Mode of Consultation
• Over-the-Counter (OTC)
• Prescription
By End Use
• Veterinary Hospitals
• Veterinary Specialty Clinics
• Others
By Distribution Channel
• Veterinary Hospital Pharmacy
• Retail Pharmacy
• Veterinary Research Institute
• Others
By Region
• North America Latin America
• Europe
• Asia Pacific
• Middle East & Africa.
Global Swine Pneumonia Market
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Swine Pneumonia Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing Economic Downturn
4.2.6 Post Covid-19 World Supply and Demand Conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Swine Pneumonia Market, By Diagnosis
5.1 Y-o-Y Growth Comparison, By Diagnosis
5.2 Global Swine Pneumonia Market Share Analysis, By Diagnosis
5.3 Global Swine Pneumonia Market Size and Forecast, By Diagnosis
5.3.1 Serologic Tests
5.3.2 Polymerase Chain Reaction (PCR) Test
5.3.3 Others
6 Global Swine Pneumonia Market, By Treatment
6.1 Y-o-Y Growth Comparison, By Treatment
6.2 Global Swine Pneumonia Market Share Analysis, By Treatment
6.3 Global Swine Pneumonia Market Size and Forecast, By Treatment
6.3.1 Vaccination
6.3.2 Antibiotics
6.3.3 Antibacterial
6.3.4 Others
7 Global Swine Pneumonia Market, By Mode of Consultation
7.1 Y-o-Y Growth Comparison, By Mode of Consultation
7.2 Global Swine Pneumonia Market Share Analysis, By Mode of Consultation
7.3 Global Swine Pneumonia Market Size and Forecast, By Mode of Consultation
7.3.1 Over-the-Counter (OTC)
7.3.2 Prescription
8Global Swine Pneumonia Market, By End Use
8.1 Y-o-Y Growth Comparison, By End Use
8.2 Global Swine Pneumonia Market Share Analysis, By End Use
8.3 Global Swine Pneumonia Market Size and Forecast, By End Use
8.3.1 Veterinary Hospitals
8.3.2 Veterinary Specialty Clinics
8.3.3 Others
9Global Swine Pneumonia Market, By Distribution Channel
9.1 Y-o-Y Growth Comparison, By Distribution Channel
9.2 Global Swine Pneumonia Market Share Analysis, By Distribution Channel
9.3 Global Swine Pneumonia Market Size and Forecast, By Distribution Channel
9.3.1 Veterinary Hospital Pharmacy
9.3.2 Retail Pharmacy
9.3.3 Veterinary Research Institute
9.3.4 Others
10 Global Swine Pneumonia Market, By Region
10.1 Global Swine Pneumonia Market Share Analysis, By Region
10.2 Global Swine Pneumonia Market Share Analysis, By Region
10.3 Global Swine Pneumonia Market Size and Forecast, By Region
11 North America Swine Pneumonia Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 North America Swine Pneumonia Market Share Analysis, By Diagnosis
11.3 North America Swine Pneumonia Market Size and Forecast, By Treatment
11.4 North America Swine Pneumonia Market Size and Forecast, By Mode of Consultation
11.5 North America Swine Pneumonia Market Size and Forecast, By End Use
11.6 North America Swine Pneumonia Market Size and Forecast, By Distribution Channel
11.7 North America Swine Pneumonia Market Size and Forecast, By Country
11.7.1 U.S.
11.7.2 Canada
11.7.3 Mexico
12 EuropeSwine Pneumonia Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Europe Swine Pneumonia Market Share Analysis, By Diagnosis
12.3 Europe Swine Pneumonia Market Size and Forecast, By Treatment
12.4 Europe Swine Pneumonia Market Size and Forecast, By Mode of Consultation
12.5 Europe Swine Pneumonia Market Size and Forecast, By End Use
12.6 Europe Swine Pneumonia Market Size and Forecast, By Distribution Channel
12.7 Europe Swine Pneumonia Market Size and Forecast, By Country
12.7.1 Germany
12.7.2 France
12.7.3 UK
12.7.4. Rest of Europe
13Asia Pacific Swine Pneumonia Market Analysis and Forecast (2023-2030)
13.1 Introduction
13.2 Asia Pacific Swine Pneumonia Market Share Analysis, By Diagnosis
13.3 Asia Pacific Swine Pneumonia Market Size and Forecast, By Treatment
13.4 Asia Pacific Swine Pneumonia Market Size and Forecast, By Mode of Consultation
13.5 Asia Pacific Activators Market Size and Forecast, By End Use
13.6 Asia Pacific Activators Market Size and Forecast, By Distribution Channel
13.6 Asia Pacific Swine Pneumonia Market Size and Forecast, By Country
13.6.1 China
13.7.2 Japan
13.8.3 India
13.8.4. Rest of Asia Pacific
14Latin America Swine Pneumonia Market Analysis and Forecast (2023-2030)
14.1 Introduction
14.2 Latin America Swine Pneumonia Market Share Analysis, By Diagnosis
14.3 Latin America Swine Pneumonia Market Size and Forecast, By Treatment
14.4 Latin America Swine Pneumonia Market Size and Forecast, By Mode of Consultation
14.5 Latin America Swine Pneumonia Market Size and Forecast, By End Use
14.6 Latin America Swine Pneumonia Market Size and Forecast, By Distribution Channel
14.7 Latin America Swine Pneumonia Market Size and Forecast, Country
14.7.1. Brazil
14.7.2.Rest of Latin America
15Middle East Swine Pneumonia Market Analysis and Forecast (2023-2030)
15.1 Introduction
15.2 Middle East Swine Pneumonia Market Share Analysis, By Diagnosis
15.3 Middle East Swine Pneumonia Market Size and Forecast, By Treatment
15.4 Middle East Swine Pneumonia Market Size and Forecast, By Mode of Consultation
15.5 Middle East Swine Pneumonia Market Size and Forecast, By End Use
15.6 Middle East Swine Pneumonia Market Size and Forecast, By Distribution Channel
15.7 Middle East Swine Pneumonia Market Size and Forecast, By Country
15.7.1. Saudi Arabia
15.7.2. UAE
15.7.3. Egypt
15.7.4. Kuwait
15.7.5. South Africa
16Competitive Analysis
16.1 Competition Dashboard
16.2 Market share Analysis of Top Vendors
16.3 Key Development Strategies
17Company Profiles
17.1 Johnson & Johnson Private Limited (U.S.)
17.1.1 Overview
17.1.2 Types
17.1.3 Key Financials
17.1.4 Business Segment & Geographic Overview
17.1.5 Key Market Developments
17.1.6 Key Strategies
17.2. Cipla Inc. (U.S.)
17.2.1 Overview
17.2.2 Types
17.2.3 Key Financials
17.2.4 Business Segment & Geographic Overview
17.2.5 Key Market Developments
17.2.6 Key Strategies
17.3. Abbott (U.S.)
17.3.1 Overview
17.3.2 Types
17.3.3 Key Financials
17.3.4 Business Segment & Geographic Overview
17.3.5 Key Market Developments
17.3.6 Key Strategies
17.4 AbbVie Inc. (U.S.)
17.4.1 Overview
17.4.2 Types
17.4.3 Key Financials
17.4.4 Business Segment & Geographic Overview
17.4.5 Key Market Developments
17.4.6 Key Strategies
17.5 Sun Pharmaceutical Industries Ltd. (India)
17.5.1 Overview
17.5.2 Types
17.5.3 Key Financials
17.5.4 Business Segment & Geographic Overview
17.5.5 Key Market Developments
17.5.6 Key Strategies
17.6 Aurobindo Pharma (India)
17.6.1 Overview
17.6.2 Types
17.6.3 Key Financials
17.6.4 Business Segment & Geographic Overview
17.6.5 Key Market Developments
17.6.6 Key Strategies
17.7 Lupin (India)
17.7.1 Overview
17.7.2 Types
17.7.3 Key Financials
17.7.4 Business Segment & Geographic Overview
17.7.5 Key Market Developments
17.7.6 Key Strategies
17.8 Sanofi (France)
17.8.1 Overview
17.8.2 Types
17.8.3 Key Financials
17.8.4 Business Segment & Geographic Overview
17.8.5 Key Market Developments
17.8.6 Key Strategies
17.9 F. Hoffmann-La Roche Ltd. (Switzerland)
17.9.1 Overview
17.9.2 Types
17.9.3 Key Financials
17.9.4 Business Segment & Geographic Overview
17.9.5 Key Market Developments
17.9.6 Key Strategies
17.10 Mallinckrodt (U.S.)
17.9.1 Overview
17.9.2 Types
17.9.3 Key Financials
17.9.4 Business Segment & Geographic Overview
17.9.5 Key Market Developments
17.9.6 Key Strategies
